SPY310.52+2.16 0.70%
DIA257.31-0.56 -0.22%
IXIC10,154.63+95.86 0.95%

Aeglea BioTherapeutics Q3 EPS $(0.66) Down From $(0.54) YoY

Aeglea BioTherapeutics (NASDAQ:AGLE) reported quarterly losses of $(0.66) per share. This is a 22.22 percent decrease over losses of $(0.54) per share from the same period last year.

Benzinga · -

Aeglea BioTherapeutics (NASDAQ:AGLE) reported quarterly losses of $(0.66) per share. This is a 22.22 percent decrease over losses of $(0.54) per share from the same period last year.